A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes.

What This Bill Does

No official summary available yet for this bill. Read the full text on Congress.gov →

Hidden provisions, earmarks, and misleading titles require reading the full bill text. Deeper analysis coming — for now, verify at Congress.gov.

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Showing only candidates tracked by PTP. View full sponsor list on Congress.gov.